12-Gene Presymptomatic Signature and Vulnerable Trilaminar Interneurons Uncovered in Early Rett Syndrome
Key Insights
Researchers at Baylor College of Medicine identified a core 12-gene presymptomatic signature disrupted exclusively in MECP2 (search)-mutant brain cells in mouse models of Rett syndrome (search).
The study revealed that trilaminar interneurons, a previously unrecognized cell type in Rett syndrome (search), exhibit the most severe transcriptional dysregulation when MeCP2 (search) function is lost.
By physically separating healthy and mutant cells from mosaic female brains, scientists discovered that genetically normal neurons are also affected by neighboring defective cells through non-cell-autonomous effects.
A landmark study from Baylor College of Medicine and the Duncan Neurological Research Institute (search) (Duncan NRI) at Texas Children's Hospital has unveiled the earliest molecular events driving Rett syndrome (search), identifying a core 12-gene presymptomatic signature and pinpointing a previously unrecognized neuronal subtype as uniquely vulnerable to MECP2 (search) dysfunction. The findings, published in Science Advances, offer new biomarkers for therapeutic monitoring and open a potential window for intervention before clinical symptoms emerge.
Rett syndrome (search) is a rare genetic neurological disorder that primarily affects girls, who typically develop normally during infancy but begin losing acquired skills—including speech, intentional movements, and social engagement—between 6 and 18 months of age. The disorder is caused by loss-of-function mutations in the X-linked gene MECP2 (search), a master transcriptional regulator that controls the activity of thousands of downstream genes in brain cells.
The Mosaic Challenge and a Technical Breakthrough
Because MECP2 (search) resides on the X chromosome, female cells undergo random X-chromosome inactivation, creating a mosaic cellular environment in which approximately half of brain cells express the healthy version of the gene (MeCP2-positive) and the other half express the mutated version (MeCP2-negative). This mosaicism has historically confounded research efforts, as traditional whole-tissue "bulk" RNA sequencing masked early cellular decay—healthy cells diluted the molecular signal of mutated cells.
To overcome this barrier, co-first authors Dr. Ashley Anderson, a postdoctoral associate in the Zoghbi Lab, and Yan Li, a graduate student in the same lab, employed a critical technical innovation: the physical separation of MeCP2 (search)-positive and MeCP2-negative cells from the same mosaic female hippocampus prior to analysis. "What makes Rett uniquely challenging to study is that the healthy and mutant cells influence each other in ways we are only beginning to understand," said Li. "By studying female mice that mirror this mosaic condition, alongside male mice carrying only the mutant copy, we begin to untangle those effects."
The team applied two complementary molecular techniques: bulk RNA sequencing to capture gene activity across whole tissue, and single-nucleus RNA sequencing to analyze gene expression in individual cells. "Using both techniques let us see the 'big picture' and zoom in on specific cell types," Li explained.
The 12-Gene Core Disease Signature
In female mice, overall changes in gene activity appeared modest when measured across whole brain tissue. However, single-cell analysis revealed a strikingly different picture. "We found that important changes were not evident in bulk measurements because they occurred only in certain cells," Li said. "This shows that in mosaic conditions like Rett syndrome (search), studying individual cells is essential to fully understand the disease."
The researchers uncovered 12 genes consistently altered at very early, presymptomatic stages of the disease—and only in Mecp2 (search)-mutant cells. "These genes were either turned up or down in the same way regardless of sex or disease severity," Anderson said. "We propose that these genes likely represent an early 'core disease signature.'" Many of these genes are involved in synaptic communication, suggesting that disruptions in how neurons connect and signal may represent one of the earliest steps in Rett syndrome (search) pathogenesis.
Trilaminar Interneurons: A Newly Identified Vulnerable Cell Type
A surprising discovery emerged from the single-nucleus data: trilaminar interneurons, a specialized neuronal subtype not previously associated with Rett syndrome (search), exhibited transcriptional disruptions that were stronger than those of any other neuron type when MeCP2 (search) was malfunctioning. These cells span multiple layers of the hippocampus and play a critical role in coordinating large-scale communication within the brain. Further studies are needed to elucidate the precise role of these interneurons in Rett syndrome.
Non-Cell-Autonomous Effects in the Mosaic Brain
The study also demonstrated that genetically normal cells do not escape unscathed in the mosaic female brain. "We found that some brain cells with normal Mecp2 (search) had changes in gene activity due to the presence of neighboring defective cells," Anderson said. "This shows that cells can be influenced by their environment and helps explain why Rett syndrome (search) can cause widespread brain dysfunction even when many cells are genetically normal."
Translational Implications
"Understanding these early and cell-specific changes provides markers to monitor efficacy of interventions and also entry points to understand the brain circuits driving Rett features," said corresponding author Dr. Huda Zoghbi, Distinguished Service Professor at Baylor, director of the Duncan NRI, and a Howard Hughes Medical Institute investigator. "If scientists can target the earliest molecular disruptions, or protect the most vulnerable cell types, it may be possible to slow or prevent the progression of Rett syndrome (search). In addition, this work informs studies of other genetic conditions that involve mosaicism or affect specific brain cell populations."
The research was supported by the National Institute of Neurological Disorders and Stroke (R01NS057819, F32N122920-01A1) and the Howard Hughes Medical Institute, with additional support from the RNA In Situ Hybridization Core facility at Baylor College of Medicine and the NIH IDDRC grant P50 HD103555 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development.